ContextVision Stock

ContextVision P/B

The P/B (Price-to-Book Ratio) of ContextVision (CONTX.OL) as of Jul 26, 2026 is 2.67. In the previous year, P/B (Price-to-Book Ratio) was 2.61 — a change of 2.28% (higher).

P/B

2.67

YoY

2.28%

Last updated:

P/B (Price-to-Book Ratio) of ContextVision is 2026 2.67 . P/B (Price-to-Book Ratio) of ContextVision was 2025 2.61 . It decreases by 2.28% higher compared to the previous year.
Access this data via the Eulerpool API

ContextVision Stock analysis

What does ContextVision do? ContextVision AB is a global provider of medical imaging software, specializing in the development and provision of advanced software for use in radiology, mammography, ultrasound, and digital pathology. They offer a wide range of products, including VOCAL for three-dimensional analysis of volume data, GOPView® US for real-time optimization of ultrasound images, and INIFY Prostate for the analysis of tissue samples in prostate cancer. The company is committed to continuous improvement and innovation, working closely with customers and partners to exchange ideas and incorporate innovative technologies in modern medicine. ContextVision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContextVision stock

P/B (Price-to-Book Ratio) of ContextVision is 2.67 in 2026.

Access this data via the Eulerpool API

Valuation — ContextVision

All Key Metrics — ContextVision